DOI: https://doi.org/10.5281/zenodo.21676331
VOLUME 3, JULY ISSUE 5
Tasawar Iqbal*
ABSTRACT
Sea salt, often regarded as a natural source of essential minerals, has garnered interest for its potential role in cancer therapy. This review explores the mechanisms by which sea salt and its mineral components, such as magnesium, zinc, selenium, and iodine, may contribute to cancer treatment and management. These minerals have been shown to influence cancer cell behavior through apoptosis induction, modulation of oxidative stress, and immune system enhancement. In vitro and in vivo studies suggest that these minerals may enhance the efficacy of chemotherapy and radiotherapy by improving the body’s response to treatment and reducing common side effects, such as fatigue, inflammation, and immune suppression. Additionally, sea salt’s potential to modulate the tumor microenvironment by regulating pH and ion balance, as well as inhibiting angiogenesis and metastasis, further emphasizes its therapeutic promise. Despite these findings, clinical evidence remains limited, and the variability in mineral composition across different sea salts poses a challenge in standardizing its use. Furthermore, regulatory and ethical considerations need to be addressed before integrating sea salt-based therapies into clinical practice. The review concludes by highlighting the need for further research to isolate active components, elucidate mechanisms, and conduct large-scale clinical trials. Such efforts are essential to determine the therapeutic benefits of sea salt in cancer treatment and to explore personalized medicine approaches tailored to individual patient profiles. Collaboration across research disciplines will be vital for advancing the clinical application of sea salt in oncology.
Keywords:
Sea Salt, Cancer Therapy, Apoptosis, Oxidative Stress, Immune
Modulation, Clinical Trials.